Literature DB >> 20080087

The role of stem cells/progenitor cells in liver carcinogenesis in glycine N-methyltransferase deficient mice.

M L Martinez-Chantar1, S C Lu, J M Mato, Z Luka, C Wagner, B A French, S W French.   

Abstract

Regeneration of the liver is inhibited as a result of a sustained increase in S-adenosylmethionine levels in glycine N-methyltransferase (GNMT)-/- mice. This sets the stage for normally dormant stem cells/progenitor cells to replicate and differentiate to replenish the liver parenchyma with liver cells. With time the stem cells/progenitor cells may aggregate and ultimately form liver tumors. This transformation of stem cells persists within the tumors that form in order to maintain the growth of the tumors that have formed. To test this hypothesis, GNMT-/- mice were maintained for 18 months and their livers were studied at intervals, in order to document the process of tumors formation and the identification of stem cells/progenitor cells involved in the process. Progenitor cell (OV-6 positive cells) hyperplasia was already established at 8 months in the livers of the GNMT-/- mice. This process was expanded at 18 months when liver tumors had formed. Stem cells which stained positive in the livers at 8 months and within tumors at 18 months (Oct 4 and CK 19 positive cells) were found. Fat 10, a marker for progenitor liver cells, was uniformly expressed by all tumors that developed at 8 and 18 months in GNMT-/- mice. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20080087      PMCID: PMC3030975          DOI: 10.1016/j.yexmp.2010.01.004

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  14 in total

Review 1.  Differential growth: from carcinogenesis to liver repopulation.

Authors:  E Laconi
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

2.  Epigenetic mechanisms regulate Mallory Denk body formation in the livers of drug-primed mice.

Authors:  Fawzia Bardag-Gorce; Joan Oliva; Jessica Villegas; Sara Fraley; Fataneh Amidi; Jun Li; Jennifer Dedes; Barbara French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2008-01-11       Impact factor: 3.362

Review 3.  Clonal adaptation during carcinogenesis.

Authors:  E Farber
Journal:  Biochem Pharmacol       Date:  1990-06-15       Impact factor: 5.858

4.  Betaine prevents Mallory-Denk body formation in drug-primed mice by epigenetic mechanisms.

Authors:  Joan Oliva; Fawzia Bardag-Gorce; Jun Li; Barbara A French; Sheila K Nguyen; Shelly C Lu; Samuel W French
Journal:  Exp Mol Pathol       Date:  2008-11-24       Impact factor: 3.362

Review 5.  Chemoprevention of hepatocarcinogenesis: S-adenosyl-L-methionine.

Authors:  Rosa M Pascale; Maria M Simile; Maria R De Miglio; Francesco Feo
Journal:  Alcohol       Date:  2002-07       Impact factor: 2.405

Review 6.  Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly.

Authors:  M R Alison; S Islam; S Lim
Journal:  J Pathol       Date:  2009-01       Impact factor: 7.996

Review 7.  Cancer stem cells and hepatocellular carcinoma.

Authors:  Zhixing Yao; Lopa Mishra
Journal:  Cancer Biol Ther       Date:  2009-09       Impact factor: 4.742

8.  Fat10 is an epigenetic marker for liver preneoplasia in a drug-primed mouse model of tumorigenesis.

Authors:  Joan Oliva; Fawzia Bardag-Gorce; Barbara A French; Jun Li; Laron McPhaul; Fataneh Amidi; Jeniffer Dedes; Amir Habibi; Sheila Nguyen; Samuel W French
Journal:  Exp Mol Pathol       Date:  2008-01-11       Impact factor: 3.362

9.  S-adenosylmethionine prevents Mallory Denk body formation in drug-primed mice by inhibiting the epigenetic memory.

Authors:  Jun Li; Fawzia Bardag-Gorce; Jennifer Dedes; Barbara Alan French; Fataneh Amidi; Joan Oliva; Samuel William French
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

10.  Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma: Implications of the gender disparity in liver cancer susceptibility.

Authors:  Yi-Jen Liao; Shih-Ping Liu; Cheng-Ming Lee; Chia-Hung Yen; Pei-Chun Chuang; Chia-Yen Chen; Ting-Fen Tsai; Shiu-Feng Huang; Yan-Hwa Wu Lee; Yi-Ming Arthur Chen
Journal:  Int J Cancer       Date:  2009-02-15       Impact factor: 7.396

View more
  3 in total

Review 1.  S-adenosylmethionine in liver health, injury, and cancer.

Authors:  Shelly C Lu; José M Mato
Journal:  Physiol Rev       Date:  2012-10       Impact factor: 37.312

2.  Dysregulated transmethylation leading to hepatocellular carcinoma compromises redox homeostasis and glucose formation.

Authors:  Curtis C Hughey; Freyja D James; Zhizhang Wang; Mickael Goelzer; David H Wasserman
Journal:  Mol Metab       Date:  2019-02-25       Impact factor: 7.422

Review 3.  The Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular Carcinoma.

Authors:  Yan Xiang; Ting Yang; Bing-Yao Pang; Ying Zhu; Yong-Ning Liu
Journal:  Stem Cells Int       Date:  2016-08-17       Impact factor: 5.443

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.